Risk Perception in Multiple Sclerosis

Clinical trial NCT05528666 · COMPLETED

Trial details

NCT number: NCT05528666
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis

Start date: 2021-09-09
Primary completion: 2021-09-17
Enrollment: 4361

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.